InvestorsHub Logo
Followers 52
Posts 2087
Boards Moderated 0
Alias Born 03/30/2016

Re: BesaoT35 post# 1336

Wednesday, 10/14/2020 3:35:04 PM

Wednesday, October 14, 2020 3:35:04 PM

Post# of 5309
What scientifically makes it different?

Maybe some research with the patent office Regarding their filing from May would help, no?

That’s out there.

Maybe it would be unwise to just dump everything into the public domain,
Which I’m sure their competition would think is fabulous.

As far as scientific journal items, they have not released their data to the public-
Just to the FDA. It’s in the FDA’s hands- not academia.

The test is not *currently being sold to the public so that is reasonable.

This is *emergency authorization pending,
Not a series of multi year trials where there is this process you speak of and we are
All
Familiar with (hopefully)

They are being close to the chest for very good
Reason,
They are using a derivative of sorts for their testreagent
Which is not much unlike the VBP patent they just filed.

Again, they may have *more ideas for applications to help people
*and maybe make money for shareholders God forbid,
And to give you what you need to feel *safe about *investing is irrelevant.

Axim ftw
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News